MENEST® Principal Display Panel (esterified estrogens) | Pfizer Medical Information - US

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

PRINCIPAL DISPLAY PANEL - 0.3 mg Tablet Bottle Label

Pfizer

NDC 61570-072-01

Menest®
(esterified estrogens
tablets, USP)

0.3 mg

100 Tablets
Rx only

PRINCIPAL DISPLAY PANEL - 0.3 mg Tablet Bottle Label

PRINCIPAL DISPLAY PANEL - 0.625 mg Tablet Bottle Label

Pfizer

NDC 61570-073-01

Menest®
(esterified estrogens
tablets, USP)

0.625 mg

100 Tablets
Rx only

PRINCIPAL DISPLAY PANEL - 0.625 mg Tablet Bottle Label

PRINCIPAL DISPLAY PANEL - 1.25 mg Tablet Bottle Label

Pfizer

NDC 61570-074-01

Menest®
(esterified estrogens
tablets, USP)

1.25 mg

100 Tablets
Rx only

PRINCIPAL DISPLAY PANEL - 1.25 mg Tablet Bottle Label

PRINCIPAL DISPLAY PANEL - 2.5 mg Tablet Bottle Label

Pfizer

NDC 61570-075-50

Menest®
(esterified estrogens
tablets, USP)

2.5 mg

50 Tablets
Rx only

PRINCIPAL DISPLAY PANEL - 2.5 mg Tablet Bottle Label

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

MENEST® Quick Finder

Pfizer samples (for eligible HCPs)

Requests for samples of prescription medications can be made by contacting Pfizer for Professionals at 1-800-505-4426 or by visiting the PfizerPro website www.pfizerpro.com.
Report an adverse event or concern about the quality of a Pfizer product

To report an adverse event related to Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY®, COVID-19 mRNA, Vaccine BNT162b2 or BNT162) or Pfizer COVID-19 Treatment (also known as PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)), and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly by visiting www.fda.gov/medwatch or by calling (800)-332-1088.
Assistance programs (for eligible patients)

Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings. Patients and physicians can contact RxPathways at (866) 706-2400 or visit the website for more information on these programs www.pfizerrxpathways.com.
Resources

Show All Hide All

ESTROGENS INCREASE THE RISK OF ENDOMETRIAL CANCER

Close clinical surveillance of all women taking estrogens is important. Adequate diagnostic measures, including endometrial sampling when indicated,...

Read more

Did you find an answer to your question? Yes No

INDICATIONS AND USAGE

Menest is indicated in the:

Treatment of moderate to severe vasomotor symptoms associated with the menopause.
Treatment of moderate to severe symptoms of vulvar and...

Read more

Did you find an answer to your question? Yes No

DOSAGE AND ADMINISTRATION

When estrogen is prescribed for a postmenopausal woman with a uterus, a progestin should also be initiated to reduce the risk of endometrial cancer. A woman without a uterus does not need progestin....

Read more

Did you find an answer to your question? Yes No

CONTRAINDICATIONS

Menest should not be used in women with any of the following conditions:

Undiagnosed abnormal genital bleeding.
Known, suspected, or history of cancer of the breast except...

Read more

Did you find an answer to your question? Yes No

WARNINGS

See Boxed Warnings.

The use of unopposed estrogens in women who have a uterus is associated with an increased risk of endometrial cancer.

...

Read more

Did you find an answer to your question? Yes No

ADVERSE REACTIONS

See Boxed Warnings, WARNINGS and PRECAUTIONS .

The following additional adverse reactions have been reported with estrogens and/or...

Read more

Did you find an answer to your question? Yes No

OVERDOSAGE

Serious ill effects have not been reported following acute ingestion of large doses of estrogen-containing drug products by young children. Overdosage of estrogen may cause nausea and vomiting, and withdrawal...

Read more

Did you find an answer to your question? Yes No

DESCRIPTION

Esterified estrogens is a mixture of the sodium salts of the sulfate esters of the estrogenic substances, principally estrone, that are of the type excreted by pregnant mares. It contains the concomitant component...

Read more

Did you find an answer to your question? Yes No

CLINICAL PHARMACOLOGY

Endogenous estrogens are largely responsible for the development and maintenance of the female reproductive system and secondary sexual characteristics. Although circulating estrogens exist in a dynamic...

Read more

Did you find an answer to your question? Yes No

Clinical Studies

Women's Health Initiative Studies

The Women's Health Initiative (WHI) enrolled a total of 27,000 predominantly healthy postmenopausal women to assess...

Read more

Did you find an answer to your question? Yes No

HOW SUPPLIED

Tablets:

0.3 mg yellow, film-coated oblong tablet imprinted with M72

100's: NDC 61570-072-01

0.625 mg orange, film-coated oblong tablet...

Read more

Did you find an answer to your question? Yes No

PATIENT INFORMATION

Menest ®

(esterified estrogens tablets, USP)

Read this PATIENT INFORMATION before you start taking Menest and read what you get each time you...

Read more

Did you find an answer to your question? Yes No

PATIENT INFORMATION

Menest ®

(esterified estrogens tablets, USP)

Read this PATIENT INFORMATION before you start taking Menest and read what you get each time you...

Read more

Did you find an answer to your question? Yes No

Rx Only

This product's label may have been updated. For current full...

Read more

Did you find an answer to your question? Yes No

Did you find an answer to your question? Yes No

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985^*

*Contact Medical Information.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Pfizer Safety

To report an adverse event related to Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY®, COVID-19 mRNA, Vaccine BNT162b2 or BNT162) or Pfizer COVID-19 Treatment (also known as PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)), and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.

If you cannot use the above website or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at
(800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatchor by calling
(800)-332-1088.